Ferric ammonium citrate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Ferric ammonium citrate
Accession Number
DB09501
Type
Small Molecule
Groups
Approved, Experimental
Description
Not Available
Structure
Thumb
Synonyms
  • Ferric ammonium citrate
  • Ferric ammonium citrate, green
External IDs
E 381 / E-381 / INS NO.381 / INS-381
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
DeritonFerric ammonium citrate (50 mg) + Choline bitartrate (50 mg) + Cyanocobalamin (14 mcg) + Dexpanthenol (5 mg) + Ergocalciferol (400 unit) + Inositol (50 mg) + Nicotinamide (45 mg) + Pyridoxine hydrochloride (2.5 mg) + Racemethionine (50 mg) + Riboflavin (5 mg) + Thiamine mononitrate (4.5 mg) + Vitamin A palmitate (5000 unit)LiquidOralNutrimetics International (Canada) Inc.1985-12-311996-09-09Canada
Geritol LiquidFerric ammonium citrate (1 mg) + Dexpanthenol (.34 mg) + Nicotinamide (1 mg) + Pyridoxine hydrochloride (.07 mg) + Riboflavin (.17 mg) + Thiamine hydrochloride (.1 mg)LiquidOralGlaxosmithkline Inc1992-12-312002-07-31Canada
Heparos Ampoules BuvablesFerric ammonium citrate (4.2 mg) + Cyanocobalamin (50 mcg)LiquidOralDesbergers LtÉe, Division Of Technilab Inc.1987-12-311999-09-17Canada
Iron, Vit & Min SuppFerric ammonium citrate (30 mg) + Choline bitartrate (82 mg) + Copper gluconate (1 mg) + Cyanocobalamin (14 mcg) + D-alpha-Tocopherol acetate (10 unit) + Folic acid (.1 mg) + Niacin (2.5 mg) + Nicotinamide (7.5 mg) + Pantothenic acid (5 mg) + Pyridoxine (1.5 mg) + Riboflavin (1.2 mg) + Thiamine (1 mg)TabletOralAvacare, Division Of Jeunique International Inc.1985-12-311996-09-09Canada
Maltlevol 12 LiqFerric ammonium citrate (2.4 mg) + Cyanocobalamin (.311 mcg) + Nicotinamide (.667 mg) + Pyridoxine (.067 mg) + Riboflavin (.067 mg) + Thiamine (.1 mg) + Vitamin A (133 unit) + Vitamin D (8.9 unit) + Vitamin E (.56 unit)LiquidOralCarter Horner Corp.1978-12-312002-02-07Canada
Maltlevol LiqFerric ammonium citrate (2.4 mg) + Nicotinamide (.22 mg) + Pyridoxine (.033 mg) + Riboflavin (.044 mg) + Thiamine (.044 mg) + Vitamin A (111 unit) + Vitamin D (8.9 unit) + Vitamin E (.56 unit)LiquidOralCarter Horner Corp.1980-12-312005-03-21Canada
Nrg Plus LiqFerric ammonium citrate (15 mg) + Biotin (100 mcg) + Cholecalciferol (400 unit) + Choline (50 mg) + Cyanocobalamin (14 mcg) + Dexpanthenol (15 mg) + Flavin mononucleotide (7.5 mg) + Inositol (50 mg) + Nicotinamide (45 mg) + Potassium (200 mg) + Potassium Iodide (.1 mg) + Pyridoxine hydrochloride (3 mg) + Thiamine mononitrate (4.5 mg) + Vitamin A palmitate (5000 unit)LiquidOralJeunique International Inc.1998-02-172006-07-20Canada
Categories
UNII
UVP74NG1C5
CAS number
1185-57-5
Weight
Average: 264.997
Monoisotopic: 264.986842
Chemical Formula
C6H11FeNO7
InChI Key
FRHBOQMZUOWXQL-UHFFFAOYSA-N
InChI
InChI=1S/C6H8O7.Fe.H3N/c7-3(8)1-6(13,5(11)12)2-4(9)10;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;1H3/q;+3;
IUPAC Name
iron(3+) 2-hydroxypropane-1,2,3-tricarboxylic acid amine
SMILES
N.[Fe+3].OC(=O)CC(O)(CC(O)=O)C(O)=O

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
3-Aza-2,3-Dihydrogeranyl DiphosphateFerric ammonium citrate can cause a decrease in the absorption of 3-Aza-2,3-Dihydrogeranyl Diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Alendronic acidFerric ammonium citrate can cause a decrease in the absorption of Alendronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
AlmasilateAlmasilate can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
AloglutamolAloglutamol can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
AluminiumAluminium can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminium acetoacetateAluminium acetoacetate can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminium glycinateAluminium glycinate can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminium phosphateAluminium phosphate can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Aluminum hydroxideAluminum hydroxide can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
AsenapineAsenapine can cause a decrease in the absorption of Ferric ammonium citrate resulting in a reduced serum concentration and potentially a decrease in efficacy.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
ChemSpider
2006378
Wikipedia
Ferric_ammonium_citrate
ATC Codes
V08CA07 — Ferric ammonium citrate

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
LiquidOral
TabletOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility106.0 mg/mLALOGPS
logP-1.3ALOGPS
logP-1.3ChemAxon
logS-0.26ALOGPS
pKa (Strongest Acidic)3.05ChemAxon
pKa (Strongest Basic)-4.2ChemAxon
Physiological Charge-3ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count4ChemAxon
Polar Surface Area132.13 Å2ChemAxon
Rotatable Bond Count5ChemAxon
Refractivity35.62 m3·mol-1ChemAxon
Polarizability15.51 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Taxonomy

Classification
Not classified

Drug created on November 30, 2015 12:10 / Updated on June 04, 2019 07:13